With a background in engineering and science, Janet Freeman-Daily has used social media to educate and unite patients to help advance research on a rare genomic mutation in lung cancer. Freeman-Daily, who was diagnosed with advanced non-small cell lung cancer in 2011, never smoked. “The more we’ve learned about the genomic drivers of cancer, the more we’ve discovered that any patient can have a genomic driver. It doesn’t matter whether we smoked or not, so why are we blaming people for having lung cancer?”
Adding chemotherapy to targeted therapy improves outcomes for people with advanced EGFR-positive non-small cell lung cancer.
by Sandra Gordon
Lessons From 20 Years Living With CancerMultiple myeloma survivor Jonathan Gluck reflects on uncertainty, and the scientific progress that has kept him living with cancer for more than two decades.
by Eric Fitzsimmons
The Enduring Importance of Cancer Disparities ResearchOpening session from AACR conference highlights how perseverance and adversity have informed cancer disparities research over the years.
by Eric Fitzsimmons
Most Cancer Survivors Don’t Meet Healthy Diet GoalsDespite research linking fruits and vegetables to cancer survival, many people do not change their eating habits after diagnosis.
by Darlene Dobkowski
 
					
 
					 
					